USD 10.64
(-3.01%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 16.73 Million USD | -35.77% |
2022 | 26.05 Million USD | 16.06% |
2021 | 22.45 Million USD | 21.48% |
2020 | 18.48 Million USD | 29.49% |
2019 | 14.27 Million USD | 1197.53% |
2018 | 1.1 Million USD | 0.0% |
2017 | 1.1 Million USD | 231.83% |
2016 | 331.5 Thousand USD | -43.03% |
2015 | 581.85 Thousand USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 14.06 Million USD | -2.4% |
2024 Q1 | 14.41 Million USD | -13.86% |
2023 Q4 | 16.73 Million USD | -32.15% |
2023 Q1 | 27.91 Million USD | 7.14% |
2023 Q2 | 27.98 Million USD | 0.25% |
2023 Q3 | 24.66 Million USD | -11.88% |
2023 FY | 16.73 Million USD | -35.77% |
2022 Q3 | 24.49 Million USD | -2.0% |
2022 Q4 | 26.05 Million USD | 6.39% |
2022 FY | 26.05 Million USD | 16.06% |
2022 Q1 | 24.17 Million USD | 7.67% |
2022 Q2 | 24.99 Million USD | 3.38% |
2021 Q4 | 22.45 Million USD | 6.85% |
2021 Q3 | 21.01 Million USD | 4.62% |
2021 FY | 22.45 Million USD | 21.48% |
2021 Q2 | 20.08 Million USD | 14.34% |
2021 Q1 | 17.56 Million USD | -4.97% |
2020 Q4 | 18.48 Million USD | -0.12% |
2020 FY | 18.48 Million USD | 29.49% |
2020 Q3 | 18.5 Million USD | -3.37% |
2020 Q2 | 19.14 Million USD | 15.66% |
2020 Q1 | 16.55 Million USD | 16.0% |
2019 Q4 | 14.27 Million USD | -5.22% |
2019 FY | 14.27 Million USD | 1197.53% |
2019 Q1 | 11.93 Million USD | 985.3% |
2019 Q2 | 11.94 Million USD | 0.07% |
2019 Q3 | 15.05 Million USD | 26.04% |
2018 Q4 | 1.1 Million USD | 0.0% |
2018 FY | 1.1 Million USD | 0.0% |
2018 Q1 | 1.1 Million USD | 0.0% |
2018 Q2 | 1.1 Million USD | 0.0% |
2018 Q3 | 1.1 Million USD | 0.0% |
2017 Q2 | 1.1 Million USD | -5.82% |
2017 Q1 | 1.16 Million USD | 252.34% |
2017 Q4 | 1.1 Million USD | 0.0% |
2017 FY | 1.1 Million USD | 231.83% |
2017 Q3 | 1.1 Million USD | 0.0% |
2016 Q3 | 331.5 Thousand USD | -39.77% |
2016 Q1 | 461.35 Thousand USD | -20.71% |
2016 Q2 | 550.4 Thousand USD | 19.3% |
2016 FY | 331.5 Thousand USD | -43.03% |
2016 Q4 | 331.5 Thousand USD | 0.0% |
2015 FY | 581.85 Thousand USD | 0.0% |
2015 Q2 | 619.4 Thousand USD | 142.9% |
2015 Q1 | 255 Thousand USD | 0.0% |
2015 Q4 | 581.85 Thousand USD | -8.28% |
2015 Q3 | 634.35 Thousand USD | 2.41% |
2014 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 1.51 Billion USD | 98.892% |
Addus HomeCare Corporation | 175.18 Million USD | 90.447% |
AirSculpt Technologies, Inc. | 99.66 Million USD | 83.209% |
Amedisys, Inc. | 487.21 Million USD | 96.565% |
American Oncology Network, Inc. | 128.32 Million USD | 86.959% |
Astrana Health, Inc. | 321.01 Million USD | 94.787% |
Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 98.884% |
IMAC Holdings, Inc. | - USD | -Infinity% |
biote Corp. | 114.87 Million USD | 85.432% |
Cryo-Cell International, Inc. | 10.89 Million USD | -53.587% |
Cross Country Healthcare, Inc. | 5.26 Million USD | -217.73% |
COMPASS Pathways plc | 33.04 Million USD | 49.365% |
DocGo Inc. | 46.49 Million USD | 64.009% |
The Ensign Group, Inc. | 1.87 Billion USD | 99.106% |
Healthcare Services Group, Inc. | 43.63 Million USD | 61.648% |
InnovAge Holding Corp. | 113.03 Million USD | 85.195% |
Assure Holdings Corp. | 14.8 Million USD | -13.035% |
LifeStance Health Group, Inc. | 511.04 Million USD | 96.725% |
Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -2446.643% |
ModivCare Inc. | 1.14 Billion USD | 98.532% |
NewGenIvf Group Limited | 332.55 Thousand USD | -4932.23% |
Novo Integrated Sciences, Inc. | 4.47 Million USD | -274.243% |
Option Care Health, Inc. | 1.16 Billion USD | 98.565% |
P3 Health Partners Inc. | 124.64 Million USD | 86.574% |
P3 Health Partners Inc. | 124.64 Million USD | 86.574% |
The Pennant Group, Inc. | 329.63 Million USD | 94.923% |
Surgery Partners, Inc. | 3.06 Billion USD | 99.453% |
Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -6645.115% |
Talkspace, Inc. | - USD | -Infinity% |
Talkspace, Inc. | - USD | -Infinity% |
The Oncology Institute, Inc. | 119.81 Million USD | 86.033% |
The Oncology Institute, Inc. | 119.81 Million USD | 86.033% |